ABVC BioPharma approves performance incentive plan contingent on $1B market cap by Dec 31, 2027

ABVC BIOPHARMA, INC.

Plan grants up to 1% of outstanding shares, capped at $10M total and $1M per recipient.
Effective only if ABVC maintains $1B market cap for 30 consecutive trading days before 2027 deadline.
Shares come from Amended 2016 Equity Incentive Plan; allocation set by Compensation Committee and Board.
No guarantee the condition will be met; plan may never be implemented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.